High-intensity focused ultrasound (HIFU) ablation is a noninvasively treatment for benign thyroid nodules that are causing distress to patients. Brian H. H. Lang, MD, Clinical Professor in the Department of Surgery at the University of Hong Kong, and chief of the Division of Endocrine Surgery at Queen Mary Hospital, is a preeminent investigator, proponent, and pioneer of this technique. He…
Focused ultrasound (FUS) ablation is an emerging treatment for breast tumours. Its use was highlighted in an October webinar focused on emerging immunotherapy research and breast cancer.
In the future, many types of open surgeries will be replaced with minimally invasive interventions, predicts Kevin Cleary, PhD, engineering lead at the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Hospital, and Professor of Pediatrics and Radiology at George Washington University, both in Washington, D.C. Surgeons and interventional radiologists will be able…
Children's National Hospital successfully performed the first-ever high-intensity focused ultrasound surgery on a pediatric patient with neurofibromatosis. This is the youngest patient to undergo HIFU treatment in the world.
For the first time in the history of MEDICA, the world-leading medical trade fair, and the industry’s number one platform for the suppliers of the medical technology industry, COMPAMED, held from 16 to 19 November 2020, took place entirely online due to the pandemic - but still won over their audiences due to their high degree of international resonance in this format too, as virtual.MEDICA and…
The Focused Ultrasound Foundation (FUS) has published its 2020 State of the Field Report, a 63-page annual update detailing new potential indications, laboratory research, clinical trials, treatments and growth in worldwide procedures performed in 2019.
Recently developed MRI techniques used to more precisely target a small area in the brain linked to Parkinson's disease and essential tremor may lead to better outcomes without surgery and with less risk of negative effects, a new study led by UT Southwestern researchers suggests.
Students from EPFL in Switzerland teamed up with startup IcosaMed to develop the SmartBra – the first piece of smart clothing that can be used for cancer prevention. “Our smart-clothing technology is designed to detect cancer at the earliest stages. It uses a non-invasive, painless method based on frequent ultrasound monitoring,” says Hugo Vuillet, one of the students on the development…
Molecular imaging is an exciting field for scientists who are willing to explore and innovate, prominent Spanish physicist José María Benlloch pointed out when he reviewed some of the most impacting and recent innovations in his portfolio during a meeting in Valencia. ‘Our mission is to develop innovative sensitive and harmless medical imaging instruments for early detection of diseases and…
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects. A new study, carried out at six hospitals across the UK, tracked 625 men with prostate cancer who received a type of treatment called high-intensity focused ultrasound (HIFU).
Illuminating blood vessels, opening the blood-brain barrier and delivering drugs. What will be the next big thing that tiny microbubbles can do?
The prostate remains the only organ where random biopsies are performed to find cancer, notes Jean-Michel Correas MD PhD, from the Necker University Hospital in Paris. If we proposed this approach to a woman to search for breast cancer, it would be outrageous, he said.
Created by the Dutch industrialist family Hilekes, in 1993 Medicor expanded beyond the Benelux countries to enter the German-speaking world as Medicor Germany GmbH, selling contrast media injectors for CT, MRI and angiography.
The current setup for MRI-guided interventions is challenging. With a physician positioned in the MRI room and an MRI operator in an adjacent room, setting scanning parameters requires communication by hand signals or via a headset that comes with inconvenient cabling.
ECR’s Josef Lissner Honorary Lecture commemorates the co-founder of the European Congress of Radiology who passed away in 2006.
Times may be tough, but GE Healthcare takes a longer term view, believing innovative technologies can transform healthcare delivery and help improve patient care.
ILJIN, the shareholder of Alpinion Medical Systems, which began as a Korean die-casting and electrical business 44 years ago, is today an international high-tech company.
ALPINION Medical Systems successfully debuted the E-CUBE 9 to the global healthcare market in 2011 and thus has won recognition in setting a high standard for the healthcare market with its advanced technologies and uncompromising performance.
The goals are ambitious: Although in the market merely four years, the start-up firm Alpinion Medical Systems states its intention to become one of the prime providers in the ultrasound segment with superior imaging and unique transducer technologies. In an interview with Daniela Zimmermann of European Hospital, Thomas Roth, Alpinion’s Managing Director, explains his corporate strategy and…
The goals are ambitious: Although in the market merely four years, the start-up firm Alpinion Medical Systems states its intention to become one of the prime providers in the ultrasound mid-range price segment. In an interview with Daniela Zimmermann of European Hospital, Thomas Roth, Alpinion’s Managing Director, explains his corporate strategy and conviction of success.
World of Ultrasound met Prof. Ioan Sporea, Prof. Gebhard Mathis and Prof. Byung Ihn Choi to ask them three questions.
In recent years the ultrasound division of Siemens Healthcare appeared to be a Sleeping Beauty slumbering on in the shadow of large slice imaging equipment such as PET/CT and MR/PET, the medical technology giant’s favourite daughters. With many of the world’s wealthy princes, particularly from India, Brazil, China, and so on, knocking on Siemens’ doors, the giant has at last decided to wake…
Medica marks the world debut for the E-Cube 9. And it is also the first strong public showing for the developer of this ultrasound system, Alpinion Medical Systems.European Hospital met with Alpinion President and Chief Executive Officer Seokbin Ko to learn what this new player emerging on the European ultrasound scene is bringing to the game.
Radiofrequency ablation (RFA) and microwave ablation repeatedly compare well with surgery in the treatment of primary and secondary liver, kidney and lung tumours and the palliative care of bone cancer. Thus oncologists are increasingly attracted to using bloodless, non-invasive treatment methods. High Intensity Focused Ultrasound (HIFU), primarily used in myoma therapy, is leading medical…
During his Honorary Lecture at the 8th Düsseldorf Breast Cancer Conference in Germany world renowned surgeon and oncologist Prof. Veronesi reflected about the prevention and treatment of breast cancer.
Italian surgeon and oncologist Prof. Dr. Umberto Veronesi, Founder and Scientific Director of the European Institute of Oncology in Milan and former National Health Minister (2000 – 2001), is considered to be one of the biggest authorities on breast cancer research of our time. Many breakthrough changings in cancer medicine sustainably go back on his researches, which once earned him also a…
Looking ahead to MEDICA 2010 (17 to 20 November) the signs are good. The high number of registrations is a sign of optimism in the medical technology industry and the number of exhibitors has already seen a significant increase in comparison to last year. With six months left to go until the fair begins, some 115,000 square metres of exhibition space had already been booked.
At ECR 2010, Philips launches the GEMINI LXL, the newest PET/CT scanner, offering many of the features available on premium systems for those working in the clinical areas of both radiology and oncology. Also making its European debut is DoseAware, a new dose-saving solution for interventional procedures. Furthermore, Philips presents its new Sonalleve MR-HIFU Fibroid Therapy system, which offers…
During a gathering of clinicians, scientists and economists at this year's Medical Technology Congress (Treffpunkt für Medizintechnik) held in Berlin's Charité Hospital, all 17 lectures focused on cancer treatments. Bettina Döbereiner reports
The Magnetic Resonance Center of the University Children's Hospital Zurich has achieved a world first breakthrough in MR-guided, non-invasive neurosurgery. Ten patients have been successfully treated by means of transcranial high-intensity focused ultrasound. This fully non-invasive procedure opens new horizons for neurosurgery and the treatment of different neurological brain disorders.
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
St. Jude Medical, Inc. has received European CE Mark approval and US Food and Drug Administration (FDA) clearance for its Epicor LP cardiac ablation system, a second generation technology that uses HIFU (high intensity focused ultrasound) for surgical ablation of cardiac tissue to disrupt abnormal cardiac electrical impulses.
By Shahram Vaezy, Associate Professor of Bioengineering at the University of Washington, Washington, Seattle, and Vesna Zderic, Assistant Professor at Electronic and Computer Engineering Department at George Washington University, Washington DC.
Better measurement standards for high-intensity focused-ultrasound (HIFU) are necessary.